Hi folks, I'm new to this board....
But my brother is an optometrist and I thought I'd relay what he told me:
So far, it looks promising. I've "prescribed" it to about half a dozen patients so far and haven't heard any complaints. I spoke with the rep last week and she said that most offices who tried it got the initial 2 dozen units. Now some are beginning to reorder.
There is a lot of positive chatter on the vision websites about the product, some VERY positive. My daughter has been using it for acne and it works pretty nicely.
It's a novel product; a dilute form of chlorine that usually isn't stable. Avenova is a fairly stable version of it that is supposed to last about a month after opening. An effective antiinfective, not an antibiotic. Patients don't ask for it since they have no idea what it is or what it does. Heck, they don't even know they have a problem when they come into the office. It's up to me to identify patients who this may work on and have them understand and buy into the "every day" disinfection regimen for their dry eye or lid problems.
So far, it looks like a winner.
BTW, the rep said that NovaBay also manufacturers a version of the exact same product specifically for dermatologists (don't know the name). Also sold only in MD offices. It is doing well too.
Now if my brother is typical, then a lot of patients are slowly being diagnosed and exposed to the product. The sales team has done an excellent job meeting with MDs and ODs and the Avenova website points to every doctor who is prescribing.
It may be a slow ramp-up, but it seems to me that sales figures will only be growing. At .55 - .59 a share, I think this is an easy double in a year, when we have a few quarters of increasing sales to show. Now if only Nova Bay would produce a great infomercial, then people would be asking for it when they have eye-doctor appointments!
